Chromatography Software Market Size & Share 2022 to 2028
Market Size by Device Type (Standalone, Integrated), by Deployment Mode (On-premise, Web-based, Cloud-based), by Application (Pharmaceutical Industry, Environmental Testing, Forensic Testing, Food & Beverage Industry), End Use & Forecast.
Report ID: GMI5204
|
Published Date: February 2022
|
Report Format: PDF
Download Free PDF
Authors:
Mariam Faizullabhoy, Gauri Wani
Chromatography Software Market Size
Chromatography Software Market size surpassed USD 471 million in 2021 and is estimated to record around 8% CAGR between 2022 and 2028. The rapidly growing population is resulting in high demand for convenience and processed food, thereby surging the demand for food safety and quality testing, fuelling the product adoption.
The surging prevalence of foodborne illnesses due to the consumption of food contaminated with a mycotoxin, pathogens, or the growth of yeasts is increasing the adoption of food safety testing in several nations to a greater extent. As per the World Health Organization (WHO), around 420,000 individuals die after eating contaminated food, resulting in the loss of 33 million healthy life years (DALYs) every year. Hence, several food testing facilities are preferring the use of chromatography software at various stages of food safety testing to analyse the quality of food is set to promote the market growth.
Chromatography software refers to the device that facilitates chromatography-based analysis. This software solution controls data from chromatography instruments, records & processes, and generates chromatograms & reports. This chromatography data software automates numerous procedures comprising data processing, instrumentation control, and database management among others. The chromatography informatics solution options range from integrated to the automated standalone software platform. These instruments find applications in materials science, drug discovery, and forensics among others.
However, the lack of a proficient laboratory workforce for chromatography software handling might have an adverse impact on the market growth. These systems are complex in nature and thus require professional workers to operate them. As per the article published in 2020, some European countries will face a shortage of skilled labour over the next decade with medical laboratories among the severely affected segment. The significant growth in technology contributes to the surging demand for skilled personnel to develop, deploy, manage, and support applications. Lack of a trained workforce, especially in developing nations may limit the use of these devices.
Owing to this shortage, some organizations are getting understaffed and experiencing reduced research volume. It also produces a variety of other negative consequences such as the inability to deliver precise needs, affecting customer satisfaction, etc. As a result, the lack of skilled labour may hamper the chromatography software industry growth.
The COVID-19 pandemic has proven to be advantageous for the chromatography software demand and rendered a positive impact on the market expansion. This is attributable to the surging use of chromatography techniques to analyse the drugs and their safety & efficacy as a COVID-19 treatment mechanism. This pandemic imposed huge pressure on healthcare infrastructure and hindered the operational capabilities of the clinical laboratories and biopharmaceutical firms. There was significant pressure on the laboratories to surge testing volume, R&D activities and deliver clinical results at rapid speed.
As per the recently published article, the overall testing volumes increased to 245% of the pre-pandemic volume. Experts anticipated considerable SARS-CoV-2 testing throughout 2021 as well as in 2022 to some extent. The increasing pressure to surge R&D and testing volume led to the demand for chromatography data software. This is due to these devices that are helping in database management, data filtering, and data processing for improved efficiency and performance with precise clinical results. Thus, the COVID-19 pandemic augmented the demand for chromatography software and is expected to witness a similar trend in the coming years.
Chromatography Software Market Analysis
There has been an upsurge in the R&D activities coupled with high investments and clinical trials for the development of innovative medications that provide valuable medical advantages. As per the article published in 2021, the rising number of research and development activities in the pharmaceutical industry led to the U.S. FDA approval of 355 novel drugs and biologics from 2009 to 2018.
Additionally, R&D expenses for 63 of these drugs calculated from SEC government filings were estimated to be USD 985 million to USD 1,336 million. According to the Congressional Budget Office of the U.S. Congress report 2018, the new approvals augmented by around 60% with 59 novel therapeutics approval. This specifies the rising R&D activities in the biotechnology and pharmaceutical sector that are predicted to increase in the near future.
Hence, an upsurge in R&D activities is associated with growing demand for chromatography data software to deliver robust and validated methods in less time and with higher efficiency is expected to propel the business revenue.
Based on device type, the chromatography software market is segmented as standalone and integrated. The standalone segment surpassed USD 126 million in 2021. Standalone software devices are all in one system that facilitates chromatography-based analysis and performs their function without the necessity of other devices. These device types majorly offer a combination of multiple technologies and an extensive range of applications, helping the scientists in pharmaceutical R&D activities to deliver focused high-quality research outcomes.
The significant applications of standalone chromatography data software are gaining significant traction in developed countries, particularly for drug discovery, cancer & genomics research, and forensic testing among others.
Moreover, in developing countries, the preference for these devices is expected to grow extensively owing to the growing prevalence of diseases requiring diagnosis & testing along with surging concerns related to food safety. These major factors are expected to positively influence the standalone segment revenue.
Based on deployment mode, the chromatography software market is segmented as on-premises, web-based, and cloud-based. The web-based chromatography software segment accounted for over 38% revenue share in 2021. This majority revenue share is highly attributed to web-based chromatography systems delivering quick accessibility over network connection at lower handling costs.
While the database is stored on a central server instead of a desktop. Increasing usage of such chromatography data software in the pharmaceutical & biotechnology industry for real-time tracking, storing of data, easy data backup, and remote access to data is anticipated to upsurge the market demand.
The launch of advanced solutions by prominent players is further set to drive the market expansion. For instance, Shimadzu Corporation has developed a web-based chromatography system that allows viewing analysis results and outputting reports for liquid chromatography in real-time. Also, a web-based software solution eliminates the requirement for additional software licenses, delivering maximum efficiency for a minimum investment.
Hence, owing to a host of benefits offered by chromatography data software in conjunction with the development of highly precise web-based software are expected to stimulate chromatography software industry landscape in the coming years.
Based on application, the chromatography software market is segmented as pharmaceutical industry, environmental testing, forensic testing, food & beverage industry, and others. The pharmaceutical industry segment is expected to reach over USD 330 million by 2028. This dominant market share is owing to the rising burden of a broad range of diseases and an increase in the usage of liquid chromatography for establishing the components of a drug’s formulation.
For instance, as per the World Health Organization, an estimated around 17.9 million people die due to cardiovascular diseases (CVDs) every year worldwide. The COVID-19 pandemic also promoted the research activities associated with drug discovery for the treatment of this infectious disease. The chromatography data software applications in the pharmaceutical industries comprise drug discovery, molecular biology, clinical research, and pharmaceutical development among others.
Chromatography software updates further provide customization of procedures, full traceability, and security features to handle increasing regulatory requirements. Thus, a host of capabilities possessed by chromatography software is projected to augment the use of these devices in the pharmaceutical industry, thereby driving the market growth significantly.
Based on end-use, the chromatography software market is segmented as pharmaceutical and biotechnology companies, academic and research institutes, testing facilities, and hospitals/clinics. The academic and research institutes segment is anticipated to expand at 7.7% CAGR from 2022 to 2028. This substantial growth is owing to the growing adoption of chromatography software in academic and research institutes, increasing research volume, etc. Owing to the emergence of the COVID-19 pandemic, several companies are focusing to introduce innovative devices comprising chromatography software for the automation of the lab.
The chromatography instruments integrated with control software support comprehensive chromatographic data processing and interpretation. Owing to numerous clinical benefits offered by the chromatographic techniques in the long run, the academic and research institutes segment is set to promote market size in the coming years.
The notable contribution of R&D at academic institutes is further expected to increase the product acceptance rate. According to the Survey of Research and Development Expenditures at Universities and Colleges, academic institutes account for around 13% of total R&D costs in the U.S. The rising number of research institutes is also contributing to the market expansion.
As per the German Academic Exchange Service, over 1000 publicly funded research institutions are operating in Germany. As a result, the increasing research volume along with the adoption of chromatography software at academic and research institutes is expected to spur industry forecasts.
U.S. chromatography software market is anticipated to reach over USD 356 million by 2028. This high revenue share is owing to growing food safety concerns, rising R&D activities & investment, etc. As per the recent estimates from the Government Accountability Office, the U.S. government spent over USD 18 billion and USD 23 billion to promote the COVID-19 vaccine development. Thus, growing spending on drug discovery for various ailments indicates the need for chromatography software used in clinical research.
Further, the presence of prominent players such as Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., and Waters Corporation among others in the country are engaged in new product development & commercialization that facilitates the industrial expansion in the U.S.
Chromatography Software Market Share
Some of the major players operating in the chromatography software industry are
Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum revenue share and promote company growth.
Recent industry developments:
Chromatography software market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:
Click here to Buy Section of this Report
By Device Type
By Deployment Mode
By Application
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →